These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 17402997)
1. Altered intestinal permeability is predictive of early relapse in children with steroid-responsive ulcerative colitis. Miele E; Pascarella F; Quaglietta L; Giannetti E; Greco L; Troncone R; Staiano A Aliment Pharmacol Ther; 2007 Apr; 25(8):933-9. PubMed ID: 17402997 [TBL] [Abstract][Full Text] [Related]
2. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792 [TBL] [Abstract][Full Text] [Related]
3. Cellobiose/mannitol sugar permeability test in children in relation to jejunal morphometry. Troncone R; Mayer M; Mugione P; Cucciardi M; Abete A; Greco L Ital J Gastroenterol; 1995 Dec; 27(9):489-93. PubMed ID: 8919317 [TBL] [Abstract][Full Text] [Related]
9. Wireless capsule endoscopy in the pediatric age group: experience and complications. Moy L; Levine J J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):516-20. PubMed ID: 17414156 [TBL] [Abstract][Full Text] [Related]
10. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505 [TBL] [Abstract][Full Text] [Related]
11. Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment. Bresci G; Parisi G; Capria A Colorectal Dis; 2008 Oct; 10(8):814-7. PubMed ID: 18834420 [TBL] [Abstract][Full Text] [Related]
12. The natural history of corticosteroid therapy for ulcerative colitis in children. Hyams J; Markowitz J; Lerer T; Griffiths A; Mack D; Bousvaros A; Otley A; Evans J; Pfefferkorn M; Rosh J; Rothbaum R; Kugathasan S; Mezoff A; Wyllie R; Tolia V; delRosario JF; Moyer MS; Oliva-Hemker M; Leleiko N; Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1118-23. PubMed ID: 16820327 [TBL] [Abstract][Full Text] [Related]
13. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis. Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519 [TBL] [Abstract][Full Text] [Related]
14. The utility of capsule endoscopy in patients with suspected Crohn's disease. Tukey M; Pleskow D; Legnani P; Cheifetz AS; Moss AC Am J Gastroenterol; 2009 Nov; 104(11):2734-9. PubMed ID: 19584828 [TBL] [Abstract][Full Text] [Related]
15. Increased intestinal permeability in patients with inflammatory bowel disease. Welcker K; Martin A; Kölle P; Siebeck M; Gross M Eur J Med Res; 2004 Oct; 9(10):456-60. PubMed ID: 15546811 [TBL] [Abstract][Full Text] [Related]
16. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B; Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104 [TBL] [Abstract][Full Text] [Related]
17. Capsule-endoscopic findings of ulcerative colitis patients. Higurashi T; Endo H; Yoneda M; Hosono K; Sakai E; Takahashi H; Inamori M; Uchiyama S; Kojima T; Kawana K; Natsumeda Y; Nagase H; Nakajima A Digestion; 2011; 84(4):306-14. PubMed ID: 22041924 [TBL] [Abstract][Full Text] [Related]
18. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal. Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172 [TBL] [Abstract][Full Text] [Related]
19. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU). Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]